Browse studies, page 703
Page 703 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival American Journal of Respiratory and Critical Care Medicine, 2018
- Application of the complex Edelim in pathogenetic management of patients with erectile dysfunction International Forum on Strategic Technology, 2021
- A clinical comparison of an endothelin receptor antagonist and phosphodiesterase-5 inhibitors for treating digital ulcers of systemic sclerosis Rheumatology, 2021
- Erectile response profiles of MEN using PDE5 inhibitors combined with intracavernosal injections as part of a penile regabilitation program after radical prostatectomy Journal of Sexual Medicine, 2023
- Sildenafil Use in Children with Pulmonary Hypertension Jornal de Pediatria, 2018
- Non-invasive alternative for phosphodiesterase inhibitor-refractory erectile dysfunction: Real-life experience with low-intensity extracorporeal shockwave therapy Medicine, 2023
- Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men PLoS ONE, 2014
- Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study BJU International, 2011
- Sexual dysfunctions induced by stress of timed intercourse and medical treatment BJU international, 2013
- Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study) Lower urinary tract symptoms, 2018
- Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon Rheumatology international, 2014
- Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of diabetic erectile dysfunction Current diabetes reviews, 2008
- Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies European urology, 2014
- Refractory cutaneous ulcers in anti-MDA5 dermatomyositis were not associated with rapidly progressive interstitial lung disease, and responded to tadalafil Seminars in arthritis and rheumatism, 2025
- Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis Advances in therapy, 2023
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The aging male : the official journal of the International Society for the Study of the Aging Male, 2026
- EEG abnormalities during treatment with tadalafil, a phosphodiesterase type 5 inhibitor Neurological research, 2009
- Synergistic Effects of ACE Insertion/Deletion and GNB3 C825T Polymorphisms on the Efficacy of PDE-5 Inhibitor in Patients with Pulmonary Hypertension Respiration; international review of thoracic diseases, 2016
- An epidemiological and knowledge, attitudes, beliefs and practices study of sexually transmitted infections in older men Singapore medical journal, 2006
- Trimodal Mini-Invasive Therapy for Stable-Phase Peyronie's Disease: A Two-Center Real-Life Prospective Pilot Study Andrology, 2026
- Daily tadalafil for the chronic phase of stuttering priapism: a case report BMC urology, 2018
- Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension BMC pulmonary medicine, 2017
- Persistence Rate with Tadalafil for Treatment of Male Lower Urinary Tract Symptoms Urologia internationalis, 2020
- Tadalafil: a new agent for erectile dysfunction The Canadian journal of urology, 2003
- Pharmacokinetics of drugs for pediatric pulmonary hypertension Pediatrics international : official journal of the Japan Pediatric Society, 2016
- Efficacy of tadalafil on symptom-specific bother in men with lower urinary tract symptoms Lower urinary tract symptoms, 2022
- Prescribing all phosphodiesterase 5 inhibitors to a patient with erectile dysfunction--a realistic and feasible option in everyday clinical practice--outcomes of a simple treatment regime European urology, 2006
- Effect of tadalafil 5mg daily treatment on penile haemodynamics in patients with erectile dysfunction Revista internacional de andrologia, 2022
- Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance The journal of sexual medicine, 2008
- Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension American journal of respiratory and critical care medicine, 2015
- Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study BMJ open, 2014
- Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma Cancer medicine, 2024
- Contralateral Pulmonary Hypertension Following Resuscitation of Unilateral Ductal Origin of a Pulmonary Artery: A Multi-institutional Review Pediatric cardiology, 2018
- High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction PloS one, 2021
- Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States Journal of managed care & specialty pharmacy, 2018
- Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia Zhonghua nan ke xue = National journal of andrology, 2012
- Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study International journal of impotence research, 2022
- Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors Respirology (Carlton, Vic.), 2014
- Psychotherapy: a missing piece in the puzzle of post radical prostatectomy erectile dysfunction rehabilitation Actas urologicas espanolas, 2014
- Carotid artery intima-media thickness can predict the response of patients with erectile dysfunction to phosphodiesterase 5 inhibitors International journal of impotence research, 2019
- Lower urinary tract symptoms and sexual dysfunction: a common approach BJU international, 2008
- Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios Drug safety, 2010
- Penile rehabilitation protocol after robot-assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency BJU international, 2010
- Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK. BJU international, 2007
- Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure Heart failure reviews, 2022
- Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study International journal of clinical practice, 2015
- Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study International journal of clinical practice, 2007
- Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia International journal of urology : official journal of the Japanese Urological Association, 2020
- Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism Revista da Associacao Medica Brasileira (1992), 2017
- Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017
- PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study International braz j urol : official journal of the Brazilian Society of Urology, 2014
- Comparison of Silodosin Monotherapy vs Silodosin With Tadalafil Add-on Therapy in Patients With Benign Prostatic Hyperplasia Urology, 2017
- Efficacy of a preprostatectomy multi-modal penile rehabilitation regimen on recovery of postoperative erectile function International journal of impotence research, 2020
- Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH. Lung, 2018
- Prospective evaluation of early postoperative male and female sexual function after radical prostatectomy with erectile nerves preservation International journal of impotence research, 2015
- The Effects of Tadalafil on Optical Coherence Tomography, Optical Coherence Tomography Angiography and Ganglion Cell Complex Parameters in Patients with Erectile Dysfunction Current eye research, 2025
- Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome Taiwanese journal of obstetrics & gynecology, 2019
- Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application Giornale italiano di cardiologia (2006), 2009
- Initial dual oral combination therapy in pulmonary arterial hypertension The European respiratory journal, 2016
- Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials American journal of respiratory and critical care medicine, 2021
- Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation ESC heart failure, 2021
- Spatial and temporal prediction of secondary crashes combining stacked sparse auto-encoder and long short-term memory Accident Analysis and Prevention, 2023
- Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia Journal of Urology, 2014
- The bioactivities of ecoenzymes derived from fruit peels and their secondary metabolites International Journal of Secondary Metabolite, 2026
- Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trials European Urology, 2015
- Mass spectral analysis of secondary metabolites from Zingiber montanum rhizome extract using UHPLC-HR-ESI-QTOF-MS/MS. Phytochemical Analysis, 2021
- Secondary analysis of existing data: opportunities and implementation Shanghai Archives of Psychiatry, 2014
- Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action Therapeutic Advances in Urology, 2015
- Implementing reactive secondary electrospray ionization based on gas-droplet reactions for VOC analysis In Analysis, 2022
- Long-term improvement during tadalafil therapy in a patient with pulmonary hypertension secondary to pulmonary Langerhans cell histiocytosis Respiratory Medicine Case Reports, 2016
- Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats American Journal of Physiology. Endocrinology and Metabolism, 2018
- Combining tadalafil and hyperbaric oxygen therapy protects against ovarian ischemia‑reperfusion damage in rats Molecular Medicine Reports, 2025
- Qualitative Secondary Analysis: A Case Exemplar Journal of Pediatric Health Care, 2017
- Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis International Urology and Nephrology, 2022
- Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial Cerebral Circulation - Cognition and Behavior, 2023
- An eco-friendly HPLC method for the sustainable analysis of the newly approved combinations of Alfuzosin and Tamsulosin, with Tadalafil in organic-solvent-free mixed-micellar systems In Analysis, 2025
- Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study Journal of Sexual Medicine, 2012
- A simple protocol for the characterization of fraudulent erectile dysfunction medicines using ion beam analytical techniques Microchemical journal (Print), 2025
- Evaluation of the effectiveness and safety of a daily dose of 5 mg of tadalafil, over an 8-week period, for improving quality of life among Korean men with andropause symptoms, including erectile dysfunction Medicine, 2018
- Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy Journal of Cellular Physiology, 2016
- Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies Journal of Sexual Medicine, 2013
- Therapeutic challenges and new therapeutic targets for combined capillary pulmonary hypertension: a review Frontiers in medicine, 2025
- New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024 European heart journal. Cardiovascular pharmacotherapy, 2025
- Development of a clinical scoring system to predict response to low-intensity shock wave therapy in clinically diagnosed vasculogenic erectile dysfunction: a prospective, non-randomized, single-arm, interventional study Sexual medicine, 2026
- Stem cell therapy for erectile dysfunction: a systematic review and meta-analysis Translational andrology and urology, 2026
- A Case Report: Lisdexamfetamine-Induced Delusional Parasitosis Cureus, 2025
- The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review Oncology research, 2025
- Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy Advances in therapy, 2026
- Research advances in connective tissue disease-associated pulmonary arterial hypertension with an emphasis on the Chinese population Frontiers in medicine, 2026
- Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease Current opinion in nephrology and hypertension, 2024
- Genetically proxied inhibition of Phosphodiesterase-5 and cancer risks: A drug-target Mendelian randomization analysis Scientific reports, 2025
- Maternal obesogenic diet during pregnancy and its impact on fetal hepatic function in baboons Obesity (Silver Spring, Md.), 2024
- Pulmonary Hypertension Associated With Interstitial Lung Diseases Chest, 2026
- Efficacy of low-intensity extracorporeal shock wave therapy for erectile dysfunction: updated meta-analysis of randomized trials Future science OA, 2025
- Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial Chest, 2023
- Treatment algorithm for pulmonary arterial hypertension The European respiratory journal, 2024
- CTD-PAH: an updated practical approach to screening, diagnosis, and management Therapeutic advances in respiratory disease, 2025
- Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities ERJ open research, 2024
- Clinical Application of Inhaled Nitric Oxide in Conditions of Excessive Right Heart Load: A Review from Neonatal Pulmonary Hypertension to Perioperative Cardiac Surgery Management Journal of cardiovascular development and disease, 2026
- Unraveling the Causal Association Between Circulating Copper Levels and Erectile Dysfunction: A Comprehensive Analysis via Bidirectional Two Sample Mendelian Randomization Study Food science & nutrition, 2025
